Results for this period
First quarter1 January 2026–31 March 2026ConsolidatedJapanese GAAPThe width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit. The dotted outline is the full-year forecast and the band inside it is the result for this period. The progress rate is the result divided by the forecast.
塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.
Steady demand for IT investment, new LifeKeeper licenses and maintenance contracts, migration of the Gluegent series to new pricing plans and growth in the user base, strong orders for systems development for financial institutions and generative AI implementation support, and increased sales of products related to Elastic N.V. contributed to the increase.
No applicable matters.
| Item | Details |
|---|---|
| Fiscal Period Classification | First quarter |
| Accounting standards | Japanese GAAP |
| Consolidated / non-consolidated | Consolidated |
| Period Covered | 1 January 2026–31 March 2026 |
| Net Sales | ¥5,895 million (YoY +18.1%) |
| Operating profit | ¥177 million (YoY +159.4%) |
| Ordinary income | ¥229 million (YoY +210.2%) |
| Profit attributable to owners of the parent | ¥133 million (YoY +242.2%) |
| Net income per share | ¥15.35 |
| Equity ratio | End of the current fiscal period 19.4 / End of previous period 20.2 |
| Total assets | ¥9,758 million |
| Net assets | ¥1,999 million |
| Full-year earnings forecast | Net Sales ¥20,000 million (YoY +4.9%) / Operating profit ¥450 million (YoY +12.1%) / Ordinary income ¥510 million (YoY +2.5%) / Net income ¥370 million (YoY +15.6%) |
| Annual Dividend Forecast | ¥0 → ¥5 |
| Segment revenue | Products and Services ¥1,213,730 thousand (YoY +4.6%), Consulting and Integration ¥874,152 thousand (YoY +0.3%), Software Sales and Solutions ¥3,807,159 thousand (YoY +28.6%) |
| Segment profit | Products and Services ¥162,282 thousand (YoY +29.8%), Consulting and Integration ¥157,490 thousand (YoY +58.6%), Software Sales and Solutions ¥76,240 thousand (YoY +108.2%) |
| Regional sales | Cumulative first-quarter consolidated period ¥5,697,483 thousand, ¥108,827 thousand, ¥62,668 thousand, ¥26,212 thousand / Cumulative first-quarter period of the previous fiscal year ¥4,796,542 thousand, ¥114,258 thousand, ¥59,690 thousand, ¥22,370 thousand |
| Depreciation and amortization | ¥20,704 thousand |
| Impairment loss | No applicable matters. |
| Breakdown of extraordinary income (loss) | Extraordinary income Gain on sale of investment securities ¥498 thousand / Extraordinary loss Loss on Disposal of Fixed Assets ¥0 thousand |
| Disclosure regarding the going concern assumption | No applicable matters. |
| Change in accounting policy | Changes due to revisions to standards No / Other changes No / Change in accounting estimate No / Restatement No |
| Changes in the scope of consolidation | New 0 companies / Excluded 0 companies / Company name No applicable matters |
| Material subsequent events | No applicable matters. |
| Availability of Supplementary Financial Results Materials | Yes |
| Availability of Financial Results Briefing | Yes (for institutional investors and analysts) |
| Issued Shares at Period-End | 8,874,400 |
| Treasury Shares at Period-End | 205,338 |
| Factors Behind Changes in Business Performance | Steady demand for IT investment, new LifeKeeper licenses and maintenance contracts, migration of the Gluegent series to new pricing plans and growth in the user base, strong orders for systems development for financial institutions and generative AI implementation support, and increased sales of products related to Elastic N.V. contributed to the increase. |
Items this document does not state (9)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.This was attributable to steady demand for IT investment driven by generative AI and AI agents; the acquisition of new LifeKeeper licenses and maintenance contracts; the migration of the Gluegent series to new pricing plans and growth in the user base; strong orders for systems development for financial institutions and generative AI implementation support; and higher sales of products related to Elastic N.V. The increase in ordinary income was also supported by interest income and gains on the valuation of derivatives.